Arthur K. Lahr

Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.

Unilever NV engages in the production and marketing of consumer goods in the nutrition, hygiene, and personal care categories. It operates through the following segments: Beauty and Personal Care, Foods and Refreshment, and Home Care. The Beauty and Personal Care segment covers the sales of skin and hair care products, deodorants and oral care products. The Foods and Refreshment segment includes the sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads. The Home Care segment is in charge of the sales of home care products such as powders, liquids and capsules, soap bars, and a wide range of cleaning products. The company was founded on November 9, 1927 and is headquartered in Rotterdam, Netherlands.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Sanquin Blood Supply Foundation provides blood supplies. Its products and services include diagnostic services , consulting services, reagents, DNA paternity testing, biological, laboratory for cell therapy, immunomonitoring services and plasma products. The company is headquartered in Amsterdam, the Netherlands.

EC Solution Group BV markets a game changing and patented product for check-in baggage. It specializes in the fields of travel software, engineering, management, financials and marketing. The company was founded by David van Hoytema, Graham Michael Kelly and Erik Jan Harkes in 2012 and is headquartered in Hague, the Netherlands.

Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands.